In a Nod to Precision Oncology, the FDA Approves Revumenib
The approval marks a significant milestone in the treatment of a rare and aggressive subtype of acute leukemia.
Read More
Lactate Is a Key Regulator of Immune Escape, Bone Marrow Fibrosis in Myelofibrosis
February 11th 2025Circulating lactate is increased in patients with myelofibrosis and corresponds with the remodeling of lactate export channel monocarboxylate transporter 4, suggesting a link with fibrosis establishment.
Read More